Refine
Estimated Years 2000-2009Clear
3,232 results foundRefine Search
Although formaldehyde is a natural metabolic product of the human body, high-dose exposure increases the risk of acute poisoning, while prolonged exposure can lead to chronic toxicity and even cancer (IARC, 2006).
Document imageDocument imageDocument imageDocument image
refid# K1EoJxNb17qM90KkLQa4qv3Q15 pages
PCB exposure was found to result in harmful effects leading Congress and the U.S.
Document imageDocument imageDocument imageDocument image
refid# 8VZwM4Kn3426XR3YnRJoejZj5108 pages
elOvk Page 1 of 100 10-K 1 k91869el0vk htm ANNUAL REPORT FOR FISCAL YEAR ENDED DECEMBER 31, 2004 SCF-FORD-3894 http //www sec gov/Archives/edgar/data/37996/000095012405001427/k91869el0vk htm 1/11/2006 elOvk Page 2 of 100 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) 0 FORM 10-K Annual report pursuant to Section 13 or 15(d) of the Secunties Exchange Act of 1934 For the fiscal year ended December 31,2004 or ' Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 1-3950 Ford Motor Company (Exact name ofRegistrant as specified m its charter) Delaware (State ofincorporation) 38-0549190 (IRS employer identification no) One American Road, Dearborn, Michigan (Address ofprincipal executive offices) 48126 (Zip code) 313-322-3000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title ofeach class Common Stock, par value $ 01 per share Name of each exchange on which registered(a) New York Stock Exchange Pacific Coast Stock Exchange 7 50% Notes Due June 10, 2043 New York Stock Exchange Ford Motor Company Capital Trust II 6 50% Cumulative Convertible Trust Preferred Securities, liquidation preference $50 per share New York Stock Exchange (a) In addition, shares of Common Stock of Ford are listed on certain stock exchanges in Europe Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required http //www sec gov/Archives/edgar/data/37996/000095012405001427/k91869el0vk htm 1/11/2006 elOvk Page 3 of 100 to file such reports), and (2) has been subject to such filing requirements for the past 90 days Yes S No__ Indicate by check mark if disclosure of delmquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant's knowledge, m definitive proxy or information statements incorporated by reference m Part III of this Form 10-K or any amendment to this Form 10-K 0 Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2) Yes / No__ As of June 30, 2004, Ford had outstanding 1,760,050,800 shares of Common Stock and 70,852,076 shares of Class B Stock Based on the New York Stock Exchange Composite Transaction closing price of the Common Stock on that date ($15 65 a share), the aggregate market value of such Common Stock was $27,544,795,020 Although there is no quoted market for our Class B Stock, shares of Class B Stock may be converted at any tune into an equal number of shares of Common Stock for the purpose of effecting the sale or other disposition of such shares of Common Stock The shares of Common Stock and Class B Stock outstanding at June 30,2004 included shares owned by persons who may be deemed to be "affiliates" of Ford We do not believe, however, that any such person should be considered to be an affiliate For information concerning ownership of outstanding Common Stock and Class B Stock, see the Proxy Statement for Ford's Annual Meetmg of Stockholders currently scheduled to be held on May 12, 2005 (our "Proxy Statement"), which is incorporated by reference under various Items of this Report As of February 24, 2005, Ford had outstanding 1,760,048,400 shares of Common Stock and 70,852,076 shares of Class B Stock Based on the New York Stock Exchange Composite Transaction closing price of the Common Stock on that date ($12 80 a share), the aggregate market value of such Common Stock was $22,528,619,520 DOCUMENT INCORPORATED BY REFERENCE* Document Where Incorporated Proxy Statement Part III (Items 10, 11, 12, 13 and 14) * As stated under various Items of this Report, only certain specified portions of such document are incorporated by reference in this Report http //www sec gov/Archives/edgar/data/37996/000095012405001427/k91869el0vk htm 1/11/2006 elOvk Page 4 of 100 ITEM 1.
Document imageDocument imageDocument imageDocument image
refid# ppznNLjBbyaxaokeQ8rNoxmjD100 pages
AR226-3340 ^0^1^ E.I.
Document imageDocument imageDocument imageDocument image
refid# 3exwwd1b1GMpLVyOL2JvLvNBy143 pages
., may be taken before Misty Perry 6 Sanders, as Commissioner and Notary Public, 7 Alabama at Large, at Anniston, Alabama, on January 8 4th, 2002, commencing at 11:00 a.m. 9 IT IS STIPULATED AND AGREED that the 10 signature to and reading of the deposition by 11 the witness is waived, the deposition to have 12 the same force and effect as if full compliance 13 were had with all laws and rules of Court 14 relating to the taking of depositions. 15 IT IS STIPULATED AND AGREED that it 16 shall not be necessary for any objections to be 17 made by counsel to any questions except as to 18 form or leading questions and that counsel may 19 make objections and assign grounds at the time 20 of trial or at the time said deposition is 21 offered in evidence or prior thereto. 22 IT IS STIPULATED AND AGREED that notice 23 of filing by the Commissioner is waived. 1 APPEARANCES 2 For the Plaintiffs: 3 CHARLES L.
Document imageDocument imageDocument imageDocument image
refid# LJdyqN3VZ90ZKadyo3vDDL54347 pages
3M M edical Department Study: T-6295.22 Analytical Report: FACT-TOX-160 LIMS E00-1668 3M Medical Department Study: T-6295.22 Analytical Report: FACT TOX-160 LIMS E00-1668 Study Title 36> Extended Recovery Study Following a 26-W eek Capsule Toxicity Study (FACT-TO X-030) with Perfluorooctane Sulfonate Acid Potassium Salt (PFOS; T-6295.22) in Cynomolgus Monkeys IIO 3 A nalytical Laboratory Report Title Determination of the Presence and Concentration of PFOS in Serum and Liver Samples of Cynomolgus Monkeys Data Requirem ent Not Applicable A u th o r 3M Environmental Laboratory Study Completion Date May 3, 2002 Performing Laboratories Sera and Liver Analyses Sera and Liver Extractions 3M Environmental Laboratory Building 2-3E-09,935 Bush Avenue St.
Document imageDocument imageDocument imageDocument image
refid# 6E0OvwZ6QNGq3dG0XgEMakO4113 pages
1 2 3 SUPERIOR COURT OF THE STATE OF CALIFORNIA 4 FOR THE COUNTY OF ORANGE 5 6 7 8 MARY GABALDON, individually and ) as Personal Representative of ) 9 the Estate of Esequiel Gabaldon; ) STEVEN GABALDON, individually; ) 10 and PAUL GABALDON, individually, ) ) 11 Plaintiffs, ) ) 12 vs. ) No. 811474 ) 13 BOEING; ROCKWELL; THE BRUSH ) BERYLLIUM COMPANY (formerly Doe ) 14 Defendant No. 1); and DOES 3 ) through 100, inclusive, ) 15 ) Defendants. ) 16 ) 17 18 DEPOSITION OF SHELDON H.
Document imageDocument imageDocument imageDocument image
refid# MM6D3dX2G7k2zzDM0vzRpwaw7182 pages
REPORTER'S RECORD VOLUME 1 OF 1 VOLUME TRIAL COURT CAUSE NO. 03CV0588 LOUISE ALTIMORE, VS.
Document imageDocument imageDocument imageDocument image
refid# E48Bz2My4wkv1rxDMLx2R2xR175 pages
Interim Report #5-Analvsis of PFBS.
Document imageDocument imageDocument imageDocument image
refid# zoejgQKv3wxjemEe6kX8Vq1Dz135 pages
ANSI Z129.1-2006 American National Standard ANSI Z129.1-2006 for Hazardous Industrial Chemicals Precautionary Labeling Licensed to Melvyn Kopstein.
Document imageDocument imageDocument imageDocument image
refid# 8RyKgJzmVx8Z0B3QjJVvkJVoB100 pages
1 2 3 SUPERIOR COURT OF THE STATE OF CALIFORNIA 4 FOR THE COUNTY OF ORANGE 5 6 7 8 MARY GABALDON, individually and ) as Personal Representative of ) 9 the Estate of Esequiel Gabaldon; ) STEVEN GABALDON, individually; ) 10 and PAUL GABALDON, individually, ) ) 11 Plaintiffs, ) ) 12 vs. ) No. 811474 ) 13 BOEING; ROCKWELL; THE BRUSH ) BERYLLIUM COMPANY (formerly Doe ) 14 Defendant No. 1); and DOES 3 ) through 100, inclusive, ) 15 ) Defendants. ) 16 ) 17 18 DEPOSITION OF SHELDON H.
Document imageDocument imageDocument imageDocument image
refid# rBmqggeQ3wzGpXM5VqeQ27vrr182 pages
Interim Report #5-Analvsis of PFBS.
Document imageDocument imageDocument imageDocument image
refid# nM8e6Vm2859wR9L7QK6aV0Yw135 pages
Report E01-1256 PFOS: A Reproduction Study with the Mallard AR226-1743 Study Title ANALYTICAPLHASE REPORTFOR PFOS: A REPRODUCTIOSNTUDY WITH THE MALLARD Data Requirement FIFRA Subdivision E, Section 71-4 OECD Guideline 206 Author Lisa A.
Document imageDocument imageDocument imageDocument image
refid# qmMVDp9bYRyw7kqQVOE8X0k2K216 pages
Report E01-1256 PFOS: A Reproduction Study with the Mallard Study Title ANALYTICAPLHASE REPORTFOR PFOS: A REPRODUCTIOSNTUDY WITH THE MALLARD Data Requirement FIFRA Subdivision E, Section 71-4 OECD Guideline 206 Author Lisa A.
Document imageDocument imageDocument imageDocument image
refid# 2qRNejZ98BqGG7VLeg10Eo8KR216 pages
1 IN THE DISTRICT COURT OF BRAZORIA COUNTY, TEXAS 2 239TH JUDICIAL DISTRICT 3 4 MANDY STAPLES, as mother and next friend of JONATHAN STAPLES (age 10), 5 JUSTIN STAPLES (age 8); and SHELBY STAPLES (AGE 5); CHRISTINA CARL, aunt 6 and guardian of the person and estate of CARLIN DAVID STAPLES, JR., (age 16); 7 and ROBERT STAPLES, as uncle and NO. 13798*JG00 8 next friend of JESSE STAPLES (age 13) 9 vs. 10 SHINTECH INCORPORATED 11 12 13 14 DEPOSITION OF OTTO WONG 15 MARCH 12, 2002 16 Volume I 17 (Pages 1 - 261) 18 19 Taken before KAREN E.
Document imageDocument imageDocument imageDocument image
refid# 3JyE2jjnpNL42zOvEX7oGwjOx260 pages